Shar Jackson discusses the importance of preventative health screenings with Dr. Steven Rabin

January 8, 2018 Providence Health Team

Share this Article
Facebook

Actress and mother of four, Shar Jackson, is a fervent advocate of health screenings for both men and women. Jackson nearly lost her mother to an illness she believes could have been prevented or caught early through testing, which inspired her to speak out about the importance of regular health screenings. Then, her uncle’s pancreatic cancer was diagnosed early due to preventative care, which ultimately saved his life. Watch what she and Dr. Steven Rabin discuss the importance of health screenings.

7 Surprising Health Problems Connected to Being Overweight

Health problems connected to being overweight

5 Surprising Reasons You Can't Donate Blood

Here are five reasons you may not be allowed to give blood. Only one in 30 people regularly gives...

Other content in this Stream

Q&A: Meet one of the investigational drug pharmacists at Providence

Shar Jackson discusses the importance of preventative health screenings with Dr. Steven Rabin

Previous Article

Next Article

Other content in this Stream

An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.

An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.

A new oral therapy is available for metastatic pancreatic cancer that has progressed after chemotherapy.

At Providence St. Joseph Hospital Eureka, cancer care extends far beyond diagnosis and treatment.

Advanced imaging technology allows clinicians to deliver targeted prostate cancer treatment while helping protect healthy tissue and reduce side effects. Dr. Amar Srivastava describes what's new.

A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.

After being diagnosed with mmelanoma while in nursing school and facing a recurrence more than a decade later, Samantha Ybaro continues to move forward with resilience, gratitude and a message of hope

When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.

After his prostate cancer progressed despite treatment, Gene found new possibilities through Pluvicto, an innovative radioligand therapy.

Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.

Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.

How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.

A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.

Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.

A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

A new study focused on stories will change health outcomes for Black women.

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

After Virginia Kuo was diagnosed with lung cancer, Providence Swedish experts were committed to helping this mom of three have the life she envisioned with her husband and family. Learn more